GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Hepalink Pharmaceutical Group Co Ltd (OTCPK:SHEZF) » Definitions » Price-to-Tangible-Book

Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Price-to-Tangible-Book : 0.82 (As of May. 19, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shenzhen Hepalink Pharmaceutical Group Co Price-to-Tangible-Book?

As of today (2024-05-19), Shenzhen Hepalink Pharmaceutical Group Co's share price is $0.7206. Shenzhen Hepalink Pharmaceutical Group Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $0.88. Hence, Shenzhen Hepalink Pharmaceutical Group Co's Price to Tangible Book Ratio of today is 0.82.

The historical rank and industry rank for Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book or its related term are showing as below:

SHEZF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.32   Med: 3.96   Max: 9.47
Current: 1.61

During the past 13 years, Shenzhen Hepalink Pharmaceutical Group Co's highest Price to Tangible Book Ratio was 9.47. The lowest was 1.32. And the median was 3.96.

SHEZF's Price-to-Tangible-Book is ranked better than
68.01% of 866 companies
in the Drug Manufacturers industry
Industry Median: 2.385 vs SHEZF: 1.61

A closely related ratio is called PB Ratio. As of today, Shenzhen Hepalink Pharmaceutical Group Co's share price is $0.7206. Shenzhen Hepalink Pharmaceutical Group Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was $1.14. Hence, Shenzhen Hepalink Pharmaceutical Group Co's P/B Ratio of today is 0.63.


Shenzhen Hepalink Pharmaceutical Group Co Price-to-Tangible-Book Historical Data

The historical data trend for Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Hepalink Pharmaceutical Group Co Price-to-Tangible-Book Chart

Shenzhen Hepalink Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.62 0.78 0.83

Shenzhen Hepalink Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.81 0.82 0.83 0.82

Competitive Comparison of Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book falls into.



Shenzhen Hepalink Pharmaceutical Group Co Price-to-Tangible-Book Calculation

Shenzhen Hepalink Pharmaceutical Group Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.7206/0.876
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Shenzhen Hepalink Pharmaceutical Group Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Shenzhen Hepalink Pharmaceutical Group Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Business Description

Traded in Other Exchanges
Address
No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading and biopharmaceutical research and development. The company distributes its products both in the domestic and overseas markets. The Group mainly operates three main business segments, including Finished dose pharmaceutical products business; Active pharmaceutical ingredients; CDMO business and Others. Geographical presence of company is in Hong Kong, United States of America, Europe, Mainland China and Other countries. Majority of the company's revenue comes from USA and Europe.

Shenzhen Hepalink Pharmaceutical Group Co (Shenzhen Hepalink Pharmaceutical Group Co) Headlines